VentureRadar helps organizations innovate and generate new growth by connecting them to emerging technologies and expertise that can solve their challenges. They discover innovative companies from across the globe using their Company Discovery Engine, which trawls the web to harvest and aggregate company information at a scale, speed, and efficiency that hasn’t previously been possible. By structuring and analyzing this information, they accurately match clients' needs with start-ups, SMEs, and other innovators that have the skills their clients need. They work directly with corporations and service providers to provide them with intelligent company discovery capabilities.

VentureRadar

MitoImmune is a clinical stage biotech company that focuses on developing drugs for diseases in high unmet needs using mitochondria / ferroptosis based approaches. 
Our molecules based on the MIT platform are basically mitochondria-targeted ferroptosis inhibitors which have been demonstrated to recover intracellular homeostasis of iron, calcium, redox, and immune and to preserve antioxidant systems such as GPX4 under pathological conditions where an abnormal increase of mitochondrial reactive oxygen species (ROS) and the accumulation of calcium and iron accumulation occur.  

MITO

COM:MITOIMMUNE

VentureRadar